Abella Mar
ActiveAbella Mar has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €75k and a net result of €13k. Equity is growing by ~30.4% per year across the filed fiscal years. Its solvency ranks better than 53% of 86 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 1.4% (low).
Checked score
Score 2024
93
/ 100
Excellent▼ -7 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability85▼-15
Solvency96▼-4
Growth52▼-26
Stability100
Bankruptcy probability, 12 months
1.4%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity ample (current ratio 2.23 against 4.58 in 2023), and 47.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
52.4%
Return on assets
8.9%
Age of the figures
20 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 16-06-2025, 45 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
not confirmed
2024
45 d early
2023
47 d early
2022
40 d early
2021
18 d early
2020
3 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€75k▲ 20.4%
2023 · €62k
2020: €28k
2021: €33k
2022: €44k
2023: €62k
2020 → 2024
Total assets
€144k▲ 91.6%
2023 · €75k
2020: €50k
2021: €49k
2022: €55k
2023: €75k
2020 → 2024
Net result
€13k▼ 30.9%
2023 · €18k
2020: €18k
2021: €4k
2022: €11k
2023: €18k
2020 → 2024
Working capital
€24k▼ 45.6%
2023 · €45k
2020: €16k
2021: €20k
2022: €33k
2023: €45k
2020 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€28k-€33k▲ 15.5%€44k▲ 34.2%€62k▲ 42.0%€75k▲ 20.4%
Operating result€26k-€8k▼ 68.3%€17k▲ 98.1%€31k▲ 84.4%€24k▼ 21.6%
Net result€18k-€4k▼ 76.0%€11k▲ 155%€18k▲ 64.7%€13k▼ 30.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 22% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €144k
Fixed assets
€99k▲ 463%
Current assets
€44k▼ 22.9%
Equity and liabilities €144k
Equity
€75k▲ 20.4%
Debt
€68k▲ 446%
The debt ratio rises from 16.7% to 47.6%: debt grows faster than equity.
Key figures and ratios
EBITDA
€35k▼
2023 · €36k
Cash flow
€23k▲
2023 · €23k
Solvency
52.4%▼
2023 · 83.3%
Current ratio
2.23▼
2023 · 4.58
Quick ratio
2.17▼
2023 · 4.48
Debt / equity
0.91▲
2023 · 0.20
ROE
17.0%▼
2023 · 29.6%
ROA
8.9%▼
2023 · 24.6%
Interest coverage
9.00▼
2023 · 28.48
Debt
€68k▲
2023 · €13k
Debt ≤ 1 year
€20k▲
2023 · €13k
Debt > 1 year
€49k
Income taxes
€7k▼
2023 · €11k
Staff costs
€0▼
2023 · €1k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€75k€144k▲
Fixed assets21/28€18k€99k▲
Tangible fixed assets22/27€18k€99k▲
Land and buildings22€8k€42k▲
Plant, machinery and equipment23€8k€10k▲
Furniture and vehicles24€2k€1k▼
Other tangible fixed assets26-€46k
Current assets29/58€57k€44k▼
Stocks and contracts in progress3€1k€1k=
Stocks30/36€1k€1k=
Amounts receivable within one year40/41€11k€14k▲
Trade receivables40€11k€10k▼
Other amounts receivable41€0€4k▲
Cash at bank and in hand54/58€43k€28k▼
Deferred charges and accrued income490/1€3k€1k▼
Equity and liabilities
Total equity and liabilities10/49€75k€144k▲
Equity10/15€62k€75k▲
Contributions10/11€10k€10k=
Reserves13€52k€65k▲
Distributable reserves133€52k€65k▲
Amounts payable17/49€13k€68k▲
Amounts payable after more than one year17-€49k
Financial debts170/4-€49k
Amounts payable within one year42/48€13k€20k▲
Current portion of amounts payable after more than one year42-€10k
Trade debts44€3k€3k▼
Suppliers440/4€3k€3k▼
Taxes, remuneration and social security45€4k€1k▼
Taxes450/3€4k€1k▼
Other amounts payable47/48€5k€6k▲
Income statement
Code20232024
Remuneration, social security and pensions62€1k€0▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€11k▲
Other operating charges640/8€2k€2k▼
Non-recurring operating charges66A€3k€0▼
Gross operating margin9900€41k€37k▼
Operating profit (loss)9901€31k€24k▼
Financial income75/76B€0€59▲
Recurring financial income75€0€59▲
Financial charges65/66B€1k€4k▲
Recurring financial charges65€1k€4k▲
Profit (loss) for the period before taxes9903€29k€20k▼
Income taxes67/77€11k€7k▼
Profit (loss) for the period9904€18k€13k▼
Profit (loss) for the period to be appropriated9905€18k€13k▼
Appropriation of the result
Profit (loss) to be appropriated9906€18k€13k▼
Transfer to equity691/2€18k€13k▼
To the legal reserve6920€0-
To other reserves6921€18k€13k▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
16-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
14-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2020net €18k ▲64.7%
Operating result €31k, net result €18k, both a record.
21-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
13-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €4k ▼76%
Net result drops to €4k, the lowest in the series; recovery starts the following year.
28-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kapellen · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Oosthoevestraat 162950 KapellenGround area
545 m²
Building footprint
102 m²
Volume, LiDAR
18 m³
Parcel 11023A0112/00M005, Flanders · tallest building 1.6 m. Linked by address, not a title deed.
1 establishment unit
Abella Mar
since 20192.297.691.359
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11023A0112/00M005 | Flanders | 545 m² | 1 · 102 m² | 1.6 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Novozymatic
BE 0761.771.979
Kapellen · Eq €82k
MDT SERVICES & TECHNOLOGIES
BE 0544.556.812
Lontzen · Eq €68k
SUPERBIOTICS
BE 0719.267.569
Eghezée · Eq €84k
PRANAROM MED
BE 0743.681.083
Ath · Eq €66k
CLARETHIS
BE 0894.880.626
Soignies · Eq €86k
Of 150 companies in sector 21100 we hold annual accounts for 108. 62 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded27-12-2019
Fiscal year end31-12
Activities, NACEBEL
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
85510Sports and recreation education
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.